Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of oryzanol and uses, applied in the field of medicine, can solve problems such as no relevant reports
Active Publication Date: 2010-11-17
BEIJING CENTURY BIOCOM PHARMA TECH
View PDF3 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although oryzanol and its purified products have a certain effect on the treatment of insomnia, there is no relevant report in the prior art on th
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0021] Take 2g of cycloartenol ferulate, 10g of lactose, 8g of microcrystalline cellulose, 10g of PVPP, 10g of PVP K30 and 2g of micropowdered silica gel, mix them evenly and press into tablets to obtain cycloartenol ferulate tablets 200 tablets.
Embodiment 2
[0022] Example 2 Cycloarpinenol Ferulate Capsules
[0023] Take 500ml of 95% ethanol, 250g of povidone K15, fully oscillate and dissolve, add 30g of cycloartenyl ferulic acid ester, heat and stir at 80°C for about 10 minutes, and when the obtained solution is concentrated to about 80ml, take it out and dry it in an oven. The obtained solid is pulverized and passed through an 80-mesh sieve, uniformly mixed with starch, then an appropriate amount of 5% starch slurry is added to granulate, dried, magnesium stearate is added to mix evenly, and capsules are obtained to obtain 1000 capsules.
[0025] Take 15g of camellia oil for injection, 0.5g of cycloartenol ferulic acid ester, stir in an oil bath at 120°C until completely dissolved, cool down to 80°C, add 1.8g of soybean oil, 0.2g of oleic acid, and stir until a uniform oil phase is formed; Take 80ml of water for injection, add 2.25g of Tween 80 and 1g of polyoxyethylene hydrogenated castor oil, stir and dissolve evenly to form an aqueous phase. Mix and stir the oil phase and water phase for half an hour to form colostrum, add water for injection to 100ml, stir evenly, use a high-pressure homogenizer to homogenize to an emulsion with a consistent particle size, decarbonize, sterilize and filter, and then fill it into a vial. 50 bottles.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses oryzanol, oryzanol extracts, cycloartenyl ferulate and 24-methylene cycloartenyl ferulate, relating to application of cycloartenyl ferulate in preparing medicaments for treating maintaining disorder type insomnia, particularly chronic maintaining disorder type insomnia. The experiments performed by the applicant show that the oryzanol, the oryzanol extracts, the cycloartenyl ferulate and the 24-methylene cycloartenyl ferulate all have certain treatment effects on treating the maintaining disorder type insomnia, wherein the cycloartenyl ferulate has an excellent effect on treating the maintaining disorder type insomnia, particularly the chronic maintaining disorder type insomnia.
Description
technical field [0001] The invention discloses oryzanol, oryzanol purified product, cycloartenyl ferulic acid ester and 24-methylene cycloartenyl ferulic acid ester, especially cycloartenyl ferulic acid ester for preparing treatment maintenance The use of the disorder-type insomnia medicine, especially the use for preparing the medicine for treating chronic maintenance disorder-type insomnia, belongs to the field of medicine. Background technique [0002] Insomnia is a pathological state with unsatisfactory sleep quality for a long time. It is usually manifested as difficulty in falling asleep, inability to fall asleep, persistent sleep difficulty, premature or intermittent awakening leading to insufficient sleep. Drugs are a common solution for insomnia treatment. For modern people, insomnia is one of the most common sleep disorders. Long-term insomnia will have harmful effects on the circulation of carbohydrates and endocrine functions in the human body, and impair the bod...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more